SFX by Ex Libris Inc.

Title:	β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE
Source:	Science [0036-8075] Vassar, Robert yr:1999

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	De Strooper, B. "A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain." Nature 398.6727 (1999): 518-522.
description	2.	Vassar R, R. "Beta-secretase (BACE) as a drug target for Alzheimer's disease." Advanced Drug Delivery Reviews 54.12 (2002): 1589-602.
description	3.	Ghetti, M D D. "A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease." Science 254.5028 (1991): 97-9.
description	4.	Selkoe, Dennis J. "The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease." Trends in cell biology 8.11 (1998): 447-453.
description	5.	Asai, M. "The novel β-secretase inhibitor KMI-429 reduces amyloid β peptide production in amyloid precursor protein transgenic and wild-type mice." Journal of neurochemistry 96.2 (2006): 533-540.
description	6.	Roberts, Susan B. "Gamma-secretase inhibitors and Alzheimer's disease." Advanced drug delivery reviews 54.12 (2002): 1579-88.
description	7.	Hardy, J. "The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics." Science 297.5580 (2002): 353-6.
description	8.	Hong, L. "Structure of the Protease Domain of Memapsin 2 (beta-Secretase) Complexed with Inhibitor." Science 290.5489 (2000): 150-153.
description	9.	Kopan, R. "Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain." Nature 393.6683 (1998): 382-6.
description	10.	De Strooper, B.. "Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein." Nature 391.6665 (1998): 387-390.
description	11.	McLean, Catriona A. "Soluble pool of A? amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease." Annals of neurology 46.6 (1999): 860-866.
description	12.	Mullan, M. "A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid." Nature genetics 1.5 (1992): 345-7.
description	13.	Vila Real, H. "Peptidomimetic β-Secretase Inhibitors Comprising a Sequence of Amyloid-β Peptide for Alzheimer’s Disease." Journal of medicinal chemistry 58.14 (2015): 5408-5418.
description	14.	"Q3 2012 Pfizer Earnings Conference Call - Final.(Broadcast transcript)." Fair Disclosure Wire (2012).
description	15.	Contestabile, A. "The history of the cholinergic hypothesis." Behavioural brain research 221.2 (2010): 334-340.
description	16.	Thinakaran, G. "Amyloid precursor protein trafficking, processing, and function." The Journal of biological chemistry 283.44 (2008): 29615-9.
description	17.	Selkoe, D J J. "Normal and abnormal biology of the beta-amyloid precursor protein." Annual Review of Neuroscience 17.1 (1994): 489-517.
description	18.	Dingwall C, C. "Spotlight on BACE: the secretases as targets for treatment in Alzheimer disease." The journal of clinical investigation 108.9 (2001): 1243-1246.
description	19.	Wang, Yongcheng C. "The X-ray structure of an antiparaliel dimer of the human amyloid precursor protein E2 domain." Molecular cell 15.3 (2004): 343-353.
description	20.	Brown, M. "Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans." Cell 100.4 (2000): 391-398.